logo

ATXS

Astria Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ATXS fundamentals

Astria Therapeutics (ATXS) released its earnings on Aug 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.57 (YoY -32.56%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.57
-32.56%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 12, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

ATXS has released its 2025 Q3 earnings report, with revenue of 706.00K, reflecting a YoY change of NaN%, and net profit of -31.64M, showing a YoY change of -28.98%. The Sankey diagram below clearly presents ATXS's revenue sources and cost distribution.

Key Indicators

Astria Therapeutics (ATXS) key financial stats and ratios, covering profitability, financial health, and leverage.
Astria Therapeutics (ATXS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Astria Therapeutics (ATXS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Astria Therapeutics (ATXS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Astria Therapeutics (ATXS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Astria Therapeutics (ATXS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield